&#xa0;
[normal]Written Evidence submitted by [bold]UK Blood Services Joint Professional Advisory Committee (BTO0030)[bold]&#xa0;[bold]Overview
[normal]&#xa0;[bold]&#xa0;
[normal]Provision of bl
[normal]ood components in the United Kingdom
[normal]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]Regulatory and policy-making arrangements
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Donor selection, donation testing and manufacturing all contribute to product safety
[normal]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Contribution of haemovigilance 
[normal]and horizon scanning to safety
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Current virus risk from transfusion
[normal]Matching donor and patient
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Appropriate Blood Use
[normal]/Patient 
[normal]Blood Management
[normal] is a key contributor to safety
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Matching the supply of blood with demand
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]January 2014
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal] 
[normal]http://www.bcshguidelines.com/4_HAEMATOLOGY_GUIDELINES.html
[normal] 
[normal]https://www.gov.uk/government/policy-advisory-groups/advisory-committee-on-the-safety-of-blood-tissues-and-organs
[normal]